LEMTRADA (alemtuzumab): Reviews and patient testimonials


Medication indications

LEMTRADA 12 mg concentrate for solution for infusion

LEMTRADA is indicated for adult patients with relapsing remitting multiple sclerosis (RRMS) with active disease defined by clinical or imaging features (see sections 4.4 and 5.1).

Route of administration: Injectable
Molecule: alemtuzumab

Patients' opinions on LEMTRADA

In brief

General satisfaction level: 10.00/10 Learn more

Treatment's effectiveness: 10.00/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 1.00/10 Learn more

Detected side effects: 3.00/10 Learn more

Improvement in the quality of life: 7.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

on 26/07/2020

round 1 was a breeze for me although the tiredness knocked me bout.

round 2 was about the same.

Only difficulties i have now is my 2 new auto immune diseases i have because of taking the chance. 

Your message

on 13/11/2019

This infusion is in two rounds a year apart, Round 1 is given daily for 5 days, Round 2 daily over 3 days

I found the first week after the infusions left me so exhausted like an MS relapse but this slowly improved over the month. You must make sure you frequently wash hands (I take a small alcho-gel everywhere n my bag)  and avoid anyone who's ill

It has been very affective and I haven't had a relapse since :) .. just waiting for my damaged nerves to try to repair... Xx

Your message

Conditions related to this medication

Fact sheet

Multiple sclerosis

See the fact sheet